The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells
Clinical Cancer Research (2004) - Comment
pubmed: 14760089  issn: 1078-0432  doi: 10.1158/1078-0432.ccr-0382-03  issn: 1557-3265 

Zhibo Yang, Rozita Bagheri-Yarmand, Rui-An Wang, Liana Adam, Vali Vassiliki Papadimitrakopoulou, Gary L. Clayman, Adel El-Naggar, Reuben Lotan, Christopher J. Barnes, Waun Ki Hong, Rakesh Kumar